2022
COVID-19 Vaccine Hesitancy Among Medicare Beneficiaries with and Without Cancer History: A US Population-based Study
Poghosyan H, Ni Z, Vlahov D, Nelson L, Nam S. COVID-19 Vaccine Hesitancy Among Medicare Beneficiaries with and Without Cancer History: A US Population-based Study. Journal Of Community Health 2022, 48: 315-324. PMID: 36427111, PMCID: PMC9702715, DOI: 10.1007/s10900-022-01174-5.Peer-Reviewed Original ResearchConceptsCOVID-19 vaccineCOVID-19 vaccine hesitancyCancer historyVaccine hesitancyMedicare beneficiariesVaccine uptakeMultivariable logistic regression modelCOVID-19 vaccine uptakeVaccine hesitancy ratesOngoing health conditionsCOVID-19 vaccinationLogistic regression modelsComplex survey designLack of recommendationsHesitancy ratesVaccine benefitsCommon reasonHesitant individualsSide effectsUS populationVaccineHealth conditionsCross-sectional dataHesitancyRegression models
2002
Regional variation in CCR5-Δ32 gene distribution among women from the US HIV Epidemiology Research Study (HERS)
Downer M, Hodge T, Smith D, Qari S, Schuman P, Mayer K, Klein R, Vlahov D, Gardner L, McNicholl J. Regional variation in CCR5-Δ32 gene distribution among women from the US HIV Epidemiology Research Study (HERS). Genes & Immunity 2002, 3: 295-298. PMID: 12140749, DOI: 10.1038/sj.gene.6363884.Peer-Reviewed Original ResearchConceptsHIV Epidemiology Research StudyRace/ethnicityHIV-1HIV Epidemiologic Research StudyAfrican AmericansCCR5-Δ32 genotypeHIV-1 transmissionEpidemiologic research studiesHost genetic factorsHispanic/LatinaBlack/African AmericanUninfected womenAA womenUS womenCCR5-Δ32US populationWhite womenFrequency of heterozygotesWomenGenetic factorsDistributions of heterozygotesRegional variationResearch studies